Hairong Zheng Selected Research

1,2- di- O- tetradecyl- 3- O- alpha- sialylglycerol (DTSL)

1/2016

NIR-Laser-Controlled Drug Release from DOX/IR-780-Loaded Temperature-Sensitive-Liposomes for Chemo-Photothermal Synergistic Tumor Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hairong Zheng Research Topics

Disease

49	Neoplasms (Cancer) 12/2022 - 01/2009
15	Glioma (Gliomas) 01/2022 - 01/2017
14	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2011
7	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 01/2017
5	Brain Neoplasms (Brain Tumor) 01/2022 - 04/2018
4	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2018
4	Atherosclerosis 03/2018 - 01/2015
3	Inflammation (Inflammations) 11/2022 - 06/2017
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2019
2	Brain Diseases (Brain Disorder) 01/2022 - 01/2021
2	Brain Ischemia (Cerebral Ischemia) 01/2022 - 02/2021
2	Myocardial Infarction 01/2022 - 01/2017
2	Central Nervous System Diseases (CNS Diseases) 01/2022 - 06/2021
2	Infarction (Infarctions) 01/2022 - 06/2019
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2021 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 05/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 09/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 04/2015
2	Disease Progression 10/2019 - 01/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 01/2012
2	Ischemia 01/2018 - 06/2017
2	Blindness (Hysterical Blindness) 01/2018 - 01/2017
2	Hyperthermia 11/2017 - 12/2016
1	Non-alcoholic Fatty Liver Disease 11/2022
1	Wounds and Injuries (Trauma) 05/2022
1	Zoonoses 05/2022
1	Echinococcosis (Hydatid Cysts) 05/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Flushing 01/2022
1	Neuroinflammatory Diseases 11/2021
1	Cysts 10/2021

Drug/Important Bio-Agent (IBA)

17	Pharmaceutical PreparationsIBA 04/2019 - 01/2009
12	Liposomes (Liposome)IBA 05/2022 - 03/2013
9	Indocyanine Green (Cardio-Green)FDA LinkGeneric 05/2022 - 02/2016
7	Peptides (Polypeptides)IBA 04/2021 - 01/2009
6	Paclitaxel (Taxol)FDA LinkGeneric 08/2018 - 05/2011
5	Protons (Proton)IBA 01/2022 - 01/2018
5	APTIBA 01/2022 - 01/2018
5	AmidesIBA 01/2022 - 01/2018
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2020 - 01/2016
4	PolymersIBA 01/2022 - 10/2017
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2018 - 01/2014
3	GoldIBA 04/2022 - 10/2019
3	AlbuminsIBA 01/2022 - 01/2016
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2021 - 11/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2019 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2009
3	Contrast MediaIBA 01/2018 - 10/2015
2	AntioxidantsIBA 04/2022 - 06/2017
2	Oxidants (Oxidizing Agents)IBA 04/2022 - 06/2017
2	Indicators and Reagents (Reagents)IBA 01/2022 - 03/2018
2	GadoliniumIBA 01/2022 - 01/2019
2	Dextrans (Dextran)FDA Link 01/2022 - 01/2021
2	ElementsIBA 01/2022 - 10/2021
2	Transferrin (beta 2 Transferrin)IBA 06/2021 - 11/2017
2	AntibodiesIBA 04/2021 - 01/2018
2	SolutionsIBA 01/2021 - 08/2018
2	cupric sulfide (CuS)IBA 01/2021 - 01/2017
2	Oxygen (Dioxygen)IBA 02/2020 - 09/2018
2	nasIBA 06/2019 - 01/2016
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019 - 05/2018
2	Silicon Dioxide (Silica)FDA LinkGeneric 11/2018 - 11/2016
2	NanocapsulesIBA 09/2018 - 11/2016
2	Photosensitizing Agents (Photosensitizers)IBA 09/2018 - 01/2016
2	LigandsIBA 05/2018 - 11/2017
2	DisulfidesIBA 04/2018 - 01/2016
2	Polysorbates (PSML)FDA Link 01/2018 - 01/2018
2	LipidsIBA 01/2018 - 04/2015
2	ferric oxide (iron oxide)IBA 01/2018 - 01/2015
2	Small Interfering RNA (siRNA)IBA 01/2017 - 07/2014
2	IntegrinsIBA 02/2016 - 10/2015
2	LipopeptidesIBA 02/2016 - 10/2015
2	2- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA 01/2016 - 01/2016
1	Choline (Choline Chloride)IBA 11/2022
1	Methionine (L-Methionine)FDA Link 11/2022
1	Phosphorus (Red Phosphorus)IBA 04/2022
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2022
1	GelatinIBA 01/2022
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2022
1	Iohexol (Omnipaque)FDA Link 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	CreatineIBA 01/2022
1	Biological ProductsIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	AgarIBA 10/2021

Therapy/Procedure

28	Therapeutics 12/2022 - 01/2009
16	Microbubbles 06/2021 - 01/2009
13	Precision Medicine 04/2022 - 02/2016
10	Drug Therapy (Chemotherapy) 05/2022 - 05/2011
8	Photothermal Therapy 05/2022 - 01/2016
7	Photochemotherapy (Photodynamic Therapy) 07/2021 - 01/2016
7	Lasers (Laser) 01/2019 - 01/2016
3	Phototherapy (Light Therapy) 05/2022 - 02/2016
2	Deep Brain Stimulation 01/2021 - 01/2019
2	Radiotherapy 02/2020 - 07/2017
2	Intravenous Administration 05/2018 - 01/2018
2	Visual Prosthesis 01/2018 - 01/2017
1	Brachytherapy 01/2022